University of Oklahoma Health Sciences Center

The Inner Circle Acknowledges, Shelly R. Swalley as a Pinnacle Life Member for her contributions to the field of Nursing Education

Retrieved on: 
Thursday, November 2, 2023

ANTLERS, Okla., Nov. 2, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Shelly R. Swalley is acknowledged as a Pinnacle Life Member for her contributions to the field of Nursing Education.

Key Points: 
  • ANTLERS, Okla., Nov. 2, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Shelly R. Swalley is acknowledged as a Pinnacle Life Member for her contributions to the field of Nursing Education.
  • Ms. Swalley pursued higher education at Oklahoma Baptist University where she earned a Bachelor of Science in Nursing in 1989.
  • She then attended The University of Oklahoma Health Sciences Center where she attained a Master of Science in Healthcare Administration in 1995.
  • With more than 30 years in the field, the nurse is an active member of the Oklahoma Nurses Association and holds a registered nurse license from the Oklahoma Board of Nursing.

Phoenix PharmaLabs’ Lead Compound, PPL-138, Offers Promise as PTSD/AUD Treatment

Retrieved on: 
Thursday, September 14, 2023

Dr. Cippitelli has been examining the ability of the drug to reduce alcohol consumption in anxiety-susceptible or anxiety-resistant PTSD subjects.

Key Points: 
  • Dr. Cippitelli has been examining the ability of the drug to reduce alcohol consumption in anxiety-susceptible or anxiety-resistant PTSD subjects.
  • “We chose this model of PTSD because it produces a wide range of comorbidities experienced by those diagnosed with PTSD.
  • A patent application for the Use of PPL-138 for treatment of PTSD/AUD has just been filed.
  • In addition to the company’s lead compound, PPL-138, Phoenix has a portfolio of 25 other compounds that have the potential to treat pain, substance abuse and addiction.

Roswell Park Study May Provide Clues to Treating Colorectal Cancer More Effectively in Younger Patients

Retrieved on: 
Sunday, June 4, 2023

That information could guide the development of new treatments for younger patients, who typically have poorer outcomes.

Key Points: 
  • That information could guide the development of new treatments for younger patients, who typically have poorer outcomes.
  • The team hopes the results of their study will help future studies zero in on new ways of treating colorectal cancer in younger patients.
  • From the world's first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer Center generates innovations that shape how cancer is detected, treated and prevented worldwide.
  • To learn more about Roswell Park Comprehensive Cancer Center and the Roswell Park Care Network, visit http://www.roswellpark.org , call 1-800-ROSWELL (1-800-767-9355) or email [email protected] .

Mersana Therapeutics Announces Upcoming Presentations at 2023 ASCO Annual Meeting

Retrieved on: 
Wednesday, April 26, 2023

CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the acceptance of multiple abstracts for poster presentations at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place in Chicago from June 2-6, 2023.

Key Points: 
  • CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the acceptance of multiple abstracts for poster presentations at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place in Chicago from June 2-6, 2023.
  • Presentation details are as follows:
    XMT-1660: A phase 1b trial of a B7-H4 targeted antibody drug conjugate (ADC) in breast, endometrial, and ovarian cancers
    Session Date & Time: June 3 from 8:00-11:00 a.m. CT
    Presenter: Debra Richardson, MD, Associate Professor, Obstetrics & Gynecology and Section Chief of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center
    Session Date & Time: June 5 from 1:15-4:15 p.m. CT
    Presenter: Debra Richardson, MD, Associate Professor, Obstetrics & Gynecology and Section Chief of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center
    Session Date & Time: June 5 from 1:15-4:15 p.m. CT
    Session Date & Time: June 5 from 1:15-4:15 p.m. CT

Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Recipients Announced

Retrieved on: 
Tuesday, April 18, 2023

Hevolution Foundation and the American Federation for Aging Research ( AFAR ) are pleased to announce the inaugural Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research recipients.

Key Points: 
  • Hevolution Foundation and the American Federation for Aging Research ( AFAR ) are pleased to announce the inaugural Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research recipients.
  • Eighteen three-year awards of $375,000 each, for a total of $6.75 Million, have been granted to support research projects in the basic biology of aging or geroscience, a research paradigm based on addressing the biology of aging and age-related disease to promote healthy aging.
  • “Some of the biggest breakthroughs in aging research today were funded first through AFAR’s grants for promising early career researchers.
  • The Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research will significantly boost support for junior faculty worldwide,” noted Stephanie Lederman, EdM, Executive Director, AFAR.

BayCare Selects Philip Minden as New St. Joseph's Hospital President

Retrieved on: 
Tuesday, April 4, 2023

CLEARWATER, Fla., April 4, 2023 /PRNewswire/ -- BayCare announced today that St. Joseph's Hospital-South President Philip Minden has been promoted to president of St. Joseph's Hospital in Tampa, effective immediately.

Key Points: 
  • CLEARWATER, Fla., April 4, 2023 /PRNewswire/ -- BayCare announced today that St. Joseph's Hospital-South President Philip Minden has been promoted to president of St. Joseph's Hospital in Tampa, effective immediately.
  • Minden will continue to oversee the hospital in Riverview during the national search for his replacement.
  • Minden now leads operations and implements strategic initiatives for BayCare's largest hospital and only trauma center.
  • With 19 years of leadership experience, Minden is well equipped to lead day to day operations and implement strategic initiatives for BayCare's largest hospital and only trauma center.

The Inner Circle Acknowledges Jerry P. George, MD, FAAD, FACEP, as a Distinguished Healthcare Professional for his contributions in the Medical Field

Retrieved on: 
Monday, March 6, 2023

DALLAS, March 6, 2023 /PRNewswire/ -- Jerry P. George, MD, FAAD, FACEP, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional for his contributions in the Medical Field.

Key Points: 
  • DALLAS, March 6, 2023 /PRNewswire/ -- Jerry P. George, MD, FAAD, FACEP, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional for his contributions in the Medical Field.
  • Dr. George earned a Bachelor of Science degree in Chemical and Biomolecular Engineering from Johns Hopkins University in 2007.
  • Dr. George completed a residency at SUNY Downstate Medical Center, where he remained until 2015.
  • Dr. George is a Pediatric Emergency Physician and treats patients from infancy through 18-years old with comprehensive healthcare for critical issues.

The Inner Circle Acknowledges, Sara Talken, MD, as a Distinguished Healthcare Professional for her contributions to the Obstetrics and Gynecological Fields

Retrieved on: 
Monday, March 6, 2023

OVERLAND PARK, Kan., March 6, 2023 /PRNewswire/ -- Sara Talken, MD, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional for her contributions to the Obstetrics and Gynecological Fields.

Key Points: 
  • OVERLAND PARK, Kan., March 6, 2023 /PRNewswire/ -- Sara Talken, MD, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional for her contributions to the Obstetrics and Gynecological Fields.
  • Dr. Talken was determined from a young age to become a doctor and work in women's healthcare.
  • The clinic's mission is to ensure that women have close access to quality healthcare from doctors they know and trust.
  • She notes that the 343-bed hospital has been serving the healthcare needs of the Kansas City metropolitan region since December 1978.

Tulsa Innovation Labs unites Oklahoma universities through new virtual health commercialization program

Retrieved on: 
Wednesday, January 18, 2023

STILLWATER, Okla., Jan. 18, 2023 /PRNewswire/ -- Oklahoma State University, the University of Oklahoma, the University of Tulsa and Tulsa Innovation Labs have announced the launch of Canopy Healthtech, a new multi-year initiative to accelerate the commercialization of virtual health innovations from Oklahoma universities.

Key Points: 
  • STILLWATER, Okla., Jan. 18, 2023 /PRNewswire/ -- Oklahoma State University, the University of Oklahoma, the University of Tulsa and Tulsa Innovation Labs have announced the launch of Canopy Healthtech, a new multi-year initiative to accelerate the commercialization of virtual health innovations from Oklahoma universities.
  • The program will catalyze start-up growth and improve health care outcomes by supporting the development of critical virtual health technologies that address regional health care delivery gaps.
  • "Oklahoma innovators have developed technologies with the potential to positively impact human health via emerging virtual and hybrid in-person care models," said Shawna Khouri, director of the Virtual Health portfolio at Tulsa Innovation Labs and architect of the Canopy Healthtech program.
  • Lane has the clinical, research and entrepreneurship experience to facilitate seamless collaboration between academic labs, health care systems and industry to transform Oklahoma research into virtual health companies that will create jobs and increase equitable health care access across the state.

Jerry P. George, MD, is being recognized by Continental Who's Who

Retrieved on: 
Tuesday, November 15, 2022

In practice for ten years, Dr. Jerry P. George is a seasoned Pediatric Emergency Physician.

Key Points: 
  • In practice for ten years, Dr. Jerry P. George is a seasoned Pediatric Emergency Physician.
  • He currently works in the Emergency Room at Children's Medical Center Plano and Medical City Dallas.
  • Additionally in 2012, Dr. George took on a residency at SUNY Downstate Medical Center, where he remained until 2015.
  • Awarded for his years in Medical practice, Dr. George has been recognized with a profile feature by Pro News Report.